ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,334Medicare Part D Prescriptions Filled, Including Refills

Rank: 229 out of 682

$724K Total Retail Price of All Prescriptions

Rank: 183 out of 682

520 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 520 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 8,974 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 437 290 S3 1 1
SIMVASTATIN 371 354 2 4
AMLODIPINE BESYLATE 357 336 3 6
LISINOPRIL 329 288 4 2
OMEPRAZOLE 270 203 5 5
LEVOTHYROXINE SODIUM 261 235 6 3
ZOLPIDEM TARTRATE 256 251 7 21
METOPROLOL SUCCINATE 220 195 8 16
FUROSEMIDE 214 179 9 7
ATORVASTATIN CALCIUM 201 189 10 11
POTASSIUM CHLORIDE 189 180 11 14
PRAVASTATIN SODIUM 172 158 12 15
HYDROCHLOROTHIAZIDE 168 142 13 12
SERTRALINE HCL 166 153 14 24
MELOXICAM 156 156 15 27
GABAPENTIN 154 122 16 9
METOPROLOL TARTRATE 153 140 17 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 139 18 34
LOSARTAN POTASSIUM 127 115 19 20
ALENDRONATE SODIUM 118 102 20 37
CRESTOR 111 102 21 22
FENOFIBRATE 107 90 22 76
LOVASTATIN 93 88 23 66
CITALOPRAM HBR 92 71 24 17
WARFARIN SODIUM 91 70 25 13
GLIMEPIRIDE 90 85 26 43
ZETIA 88 86 27 69
LANSOPRAZOLE 88 74 27 85
ALLOPURINOL 78 74 29 32
CELEBREX 74 65 30 80
ATENOLOL 74 74 30 18
DIOVAN 74 71 30 42
TAMSULOSIN HCL 73 73 33 33
LOSARTAN-HYDROCHLOROTHIAZIDE 70 70 34 56
CYMBALTA 68 46 35 51
SINGULAIR 66 54 36 63
TRIAMTERENE-HYDROCHLOROTHIAZID 66 64 36 174
DIGOXIN 65 53 38 46
FLUOXETINE HCL 65 53 38 60
AMITRIPTYLINE HCL 63 54 R 40 50
CLOPIDOGREL 62 56 41 25
NEXIUM 61 51 42 19
FLUTICASONE PROPIONATE 60 53 43 36
TRIAMTERENE-HCTZ 56 56 44 57
RAMIPRIL 55 54 45 81
ADVAIR DISKUS 53 47 46 47
DETROL LA 53 53 46 226
SYNTHROID 52 38 48 59
METFORMIN HCL 51 43 49 8
AMLODIPINE BESYLATE-BENAZEPRIL 51 48 49 77
SPIRIVA 50 41 51 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.